Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Runtai Pharmaceutical, formerly known as Zhejiang Runtai Chemical, is a leading manufacturer of pharmaceutical APIs and nutraceutical ingredients specializing in joint health. The company is a major global supplier of glucosamine derivatives, including glucosamine hydrochloride and glucosamine sulfate, as well as chondroitin sulfate. Based in Zhoushan, China, Runtai Pharmaceutical operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. Its products are widely used in both pharmaceutical treatments for osteoarthritis and as key components in the global dietary supplement market. The company maintains a strong international presence, exporting high-purity ingredients to major markets in North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Runtai Chemical.